DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Peterson ED, Ashton V, Chen YW, Wu B, Spyropoulos AC.
Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation.
Am Heart J 2019;
212: 113-119
We do not assume any responsibility for the contents of the web pages of other providers.